Deficiency of ADAMTS13 and thrombotic thrombocytopenic purpura
Author:
Affiliation:
1. Correspondence: Han-Mou Tsai, Montefiore Medical Center/Albert Einstein College of Medicine, Division of Hematology, Bronx, NY 10467; e-mail:
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/100/10/3839/1252573/h82202003838b.pdf
Reference6 articles.
1. Von Willebrand factor-cleaving protease (ADAMTS13) in thrombocytopenic disorders: a severely deficient activity is specific for thrombotic thrombocytopenic purpura.;Bianchi;Blood.,2002
2. Antibodies to von Willebrand factor-cleaving protease in acute thrombotic thrombocytopenic purpura.;Tsai;N Engl J Med.,1998
3. Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.;Levy;Nature.,2001
4. von Willebrand factor and von Willebrand factor-cleaving metalloprotease activity in Escherichia coli O157:H7- associated hemolytic uremic syndrome.;Tsai;Pediatr Res.,2001
5. Von Willebrand factor-cleaving protease activity and proteolysis of von Willebrand factor in bone marrow transplant-associated thrombotic microangiopathy.;Arai;Hematol J.,2001
Cited by 21 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of the efficacy and safety of caplacizumab versus placebo in thrombotic thrombocytopenic purpura: a meta-analysis and systematic review based on randomized controlled trials;Annals of Translational Medicine;2022-06
2. Association between ADAMTS13 deficiency and cardiovascular events in chronic hemodialysis patients;Scientific Reports;2021-11-24
3. Von Willebrand Factor and ABO Blood Group;Trends in Glycoscience and Glycotechnology;2020-09-25
4. Von Willebrand Factor and ABO Blood Group;Trends in Glycoscience and Glycotechnology;2020-09-25
5. Predictors of relapse and efficacy of rituximab in immune thrombotic thrombocytopenic purpura;Blood Advances;2019-05-10
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3